126.67MMarket Cap-12.12P/E (TTM)
27.1050High23.0434Low26.51KVolume25.4000Open25.8200Pre Close662.46KTurnover0.85%Turnover RatioLossP/E (Static)5.28MShares38.500052wk High25.61P/B74.92MFloat Cap1.545052wk Low--Dividend TTM3.12MShs Float240.0000Historical High--Div YieldTTM15.73%Amplitude1.3695Historical Low24.9930Avg Price1Lot Size
Monopar Therapeutics Stock Forum
Monopar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CHANDLER ROBINSON(19.2%),MICHAEL BROWN(17.1%), etc.
Cash and Net Loss
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
Monopar project...
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
No comment yet